Maternal serum PFOA concentration and DNA methylation in cord blood: A pilot study

Environ Res. 2017 Oct:158:174-178. doi: 10.1016/j.envres.2017.06.013. Epub 2017 Jun 20.

Abstract

Perfluorooctanoic acid (PFOA), a perfluoroalkyl substance, is commonly detected in the serum of pregnant women and may impact fetal development via epigenetic re-programming. In a pilot study, we explored associations between serum PFOA concentrations during pregnancy and offspring peripheral leukocyte DNA methylation at delivery in women with high (n = 22, range: 12-26ng/mL) and low (n = 22, range: 1.1-3.1ng/mL) PFOA concentrations. After adjusting for cell type, child sex, and income, we did not find differences in CpG methylation in the two exposure groups that reached epigenome-wide significance. Among the 20 CpGs with the lowest p-values we found that seven CpG sites in three genes differed by exposure status. In a confirmatory cluster analysis, these 20 CpGs clustered into two groups that perfectly identified exposure status. Future studies with larger sample sizes should confirm these findings and determine if PFOA-associated changes in DNA methylation underlie potential health effects of PFOA.

Keywords: Children's health; DNA methylation; Environmental chemicals; Epidemiology; Perfluoroalkyl substances.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Caprylates / blood*
  • Caprylates / toxicity*
  • DNA Methylation*
  • Environmental Pollutants / blood
  • Environmental Pollutants / toxicity
  • Female
  • Fetal Blood / chemistry*
  • Fluorocarbons / blood*
  • Fluorocarbons / toxicity*
  • Humans
  • Infant, Newborn
  • Leukocytes / drug effects*
  • Maternal Exposure*
  • Ohio
  • Pilot Projects
  • Prospective Studies

Substances

  • Caprylates
  • Environmental Pollutants
  • Fluorocarbons
  • perfluorooctanoic acid